Literature DB >> 19916931

Inhibition of C5-cytosine-DNA-methyltransferases.

O V Kirsanova1, N A Cherepanova, E S Gromova.   

Abstract

Changes in the methylation pattern of genomic DNA, particularly hypermethylation of tumor suppressor genes, occur at early stages of tumor development. Errors in DNA methylation contribute to both initiation and progression of various cancers. This stimulates significant interest in searching for inhibitors of C5-DNA-methyltransferases (MTases). Here we review the known nucleoside mechanism-based reversible and irreversible inhibitors of the MTases, as well as non-nucleoside ones, and discuss their inhibitory mechanisms and application for MTase investigations and cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19916931     DOI: 10.1134/s0006297909110017

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  1 in total

1.  Symmetric dimeric bisbenzimidazoles DBP(n) reduce methylation of RARB and PTEN while significantly increase methylation of rRNA genes in MCF-7 cancer cells.

Authors:  Svetlana V Kostyuk; Margarita A Kvasha; Daria A Khrabrova; Olga V Kirsanova; Elizaveta S Ershova; Elena M Malinovskaya; Natalia N Veiko; Alexander A Ivanov; Vasiliy S Koval; Alexei L Zhuze; Vadim H Tashlitsky; Pavel E Umriukhin; Sergey I Kutsev; Elizaveta S Gromova
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.